< Back to all clusters
[HEALTH] · South Korea · 5 sources

started · updated

South Korea passes law restricting telemedicine platform wholesaling

The South Korean National Assembly has passed an amendment to the Pharmaceutical Affairs Act, often referred to as the ‘Doctor Now Prevention Act’. The legislation restricts telemedicine platforms from simultaneously operating as pharmaceutical wholesalers to prevent potential conflicts of interest and illegal rebates.

While the pharmaceutical industry has welcomed the move as a necessary measure for safety and to prevent interest conflicts, the venture and startup sectors have expressed strong opposition. Organizations such as the Korea Startup Forum and the Venture Business Association argue that the law stifles innovation by banning entire business models rather than regulating specific problematic behaviors.

Simultaneously, the South Korean government has announced plans to discuss expanding medicine delivery services to all telemedicine patients, moving beyond the current restrictions that limit delivery to vulnerable groups like the disabled and residents of remote areas. This proposal has sparked intense debate. The Ministry of Health and Welfare intends to form a multi-ministry consultative body to address safety concerns, including drug misuse, delivery quality, and medication guidance. In response, the Korean Pharmaceutical Association has declared a boycott of these discussions, citing concerns over the potential collapse of the healthcare system and the prioritization of platform capital over public health.

Entities

Doctor Now · Korea Startup Forum · Korean Pharmaceutical Association · Ministry of Health and Welfare · Ministry of SMEs and Startups · National Assembly of South Korea · Office for Government Policy Coordination · Remote Medical Industry Association

Claims

What the coverage asserts, and how many sources carry each claim.